Curcumol Synergizes with Cisplatin in Osteosarcoma by Inhibiting M2-like Polarization of Tumor-Associated Macrophages

Osteosarcoma is the most prevalent bone cancer, and chemotherapy is still an indispensable treatment in its clinical practice. Cisplatin (CDDP) has become the most commonly used agent for osteosarcoma, although the outcomes of CDDP chemotherapy remain unsatisfactory because of frequent resistance. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Jincheng, Jin, Jialu, Chen, Ting, Zhou, Qian
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318016/
https://www.ncbi.nlm.nih.gov/pubmed/35889217
http://dx.doi.org/10.3390/molecules27144345

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318016/
https://www.ncbi.nlm.nih.gov/pubmed/35889217
http://dx.doi.org/10.3390/molecules27144345

Ejemplares similares